The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
Torben Redmer(German Cancer Research Center), Christian Regenbrecht(Itasca Consultants (Germany))
Cited by 65
Related Papers
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
|Nature Communications|2017|348
The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells
|PLoS ONE|2014|99
Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures
|PLoS Genetics|2019|81
CD271 determines migratory properties of melanoma cells
|Scientific Reports|2017|44
Decoding molecular programs in melanoma brain metastases
|medRxiv|2022|1